{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:58:16Z","timestamp":1790200696982,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can J Public Health"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1007\/bf03405330","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T16:10:50Z","timestamp":1568304650000},"page":"126-131","source":"Crossref","is-referenced-by-count":11,"title":["Impact of Antibiotic Administrative Restrictions on Trends in Antibiotic Resistance"],"prefix":"10.17269","volume":"97","author":[{"given":"D. A.","family":"Marshall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"McGeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Grootendorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Buitendyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Simonyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Jaszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M.","family":"MacLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. E.","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,3,1]]},"reference":[{"issue":"Suppl","key":"BF03405330_CR1","first-page":"106","volume":"115","author":"DE Low","year":"2000","unstructured":"Low, DE. Appropriate antibiotic use: Reducing the emergence and dissemination of resistance. Int J Clin Pract 2000;115Suppl:106\u201310.","journal-title":"Int J Clin Pract"},{"issue":"Suppl7","key":"BF03405330_CR2","first-page":"i","volume":"23","author":"Controlling antimicrobial resistance.","year":"1997","unstructured":"Controlling antimicrobial resistance. An integrated action plan for Canadians. Can Commun Dis Rep 1997;23(Suppl 7):i\u201332, i.","journal-title":"Can Commun Dis Rep"},{"key":"BF03405330_CR3","unstructured":"Health Canada. \n                    https:\/\/doi.org\/www.hc-sc.gc.ca\n                    \n                  \/english\/antires\/htm. 2003."},{"issue":"4","key":"BF03405330_CR4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJM199907223410403","volume":"341","author":"DK Chen","year":"1999","unstructured":"Chen DK, McGeer A, de Azavedo JC, Low, DE. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med 1999;341(4):233\u201339.","journal-title":"N Engl J Med"},{"issue":"5","key":"BF03405330_CR5","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1128\/AAC.46.5.1295-1301.2002","volume":"46","author":"DE Low","year":"2002","unstructured":"Low DE, de Azavedo J, Weiss K, Mazzulli T, Kuhn M, Church D, et al. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in Canada during 2000. Antimicrob Agents Chemother 2002;46(5):1295\u2013301.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"BF03405330_CR6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0732-8893(98)00081-9","volume":"32","author":"GV Doern","year":"1998","unstructured":"Doern GV, Pfaller MA, Erwin ME, Brueggemann AB, Jones, RN. The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada\u20141997 results from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis 1998;32(4):313\u201316.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"SupplA","key":"BF03405330_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/jac\/40.suppl_1.59","volume":"40","author":"RF Grossman","year":"1997","unstructured":"Grossman, RF. The role of fluoroquinolones in respiratory tract infections. J Antimicrob Chemother 1997;40(Suppl A):59\u201362.","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl3","key":"BF03405330_CR8","doi-asserted-by":"publisher","first-page":"S206","DOI":"10.1086\/321849","volume":"33","author":"DE Low","year":"2001","unstructured":"Low, DE. Antimicrobial drug use and resistance among respiratory pathogens in the community. Clin Infect Dis 2001;33(Suppl 3):S206\u2013S213.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"BF03405330_CR9","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/jac\/43.4.459","volume":"43","author":"IM Gould","year":"1999","unstructured":"Gould, IM. A review of the role of antibiotic policies in the control of antibiotic resistance. J Antimicrob Chemother 1999;43(4):459\u201365.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"BF03405330_CR10","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1093\/clinids\/14.6.1186","volume":"14","author":"H Westh","year":"1992","unstructured":"Westh H, Jarlov JO, Kjersem H, Rosdahl, VT. The disappearance of multiresistant Staphylococcus aureus in Denmark: Changes in strains of the 83A complex between 1969 and 1989. Clin Infect Dis 1992;14(6):1186\u201394.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"BF03405330_CR11","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1056\/NEJM199708143370701","volume":"337","author":"H Seppala","year":"1997","unstructured":"Seppala H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 1997;337(7):441\u201346.","journal-title":"N Engl J Med"},{"issue":"1","key":"BF03405330_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1086\/338232","volume":"34","author":"J Beilby","year":"2002","unstructured":"Beilby J, Marley J, Walker D, Chamberlain N, Burke M. Effect of changes in antibiotic prescribing on patient outcomes in a community setting: A natural experiment in Australia. Clin Infect Dis 2002;34(1):55\u201364.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"BF03405330_CR13","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1128\/AAC.47.6.1867-1874.2003","volume":"47","author":"GG Zhanel","year":"2003","unstructured":"Zhanel GG, Palatnick L, Nichol KA, Bellyou T, Low DE, Hoban, DJ. Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: Results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002. Antimicrob Agents Chemother 2003;47(6):1867\u201374.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF03405330_CR14","volume-title":"DQTC Bulletin","author":"Antibiotic Resistance: Antibiotic reviewOntario Drug Benefit Formulary listing changes.","year":"2001","unstructured":"Antibiotic Resistance: Antibiotic review and Ontario Drug Benefit Formulary listing changes. DQTC Bulletin 2001; February."},{"key":"BF03405330_CR15","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing. Tenth Informational Supplement. Tenth Informational Supplement M100-S12 NCCCLS","author":"National Committee for Clinical Laboratory Standards.","year":"2002","unstructured":"National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing. Tenth Informational Supplement. Tenth Informational Supplement M100-S12 NCCCLS 2002; Wayne, PA, USA."},{"key":"BF03405330_CR16","volume-title":"SAS System for Forecasting Time Series","author":"JC Brocklebank","year":"1986","unstructured":"Brocklebank JC, Dickey, DA. SAS System for Forecasting Time Series. Cary, NC: SAS Institute, 1986."},{"key":"BF03405330_CR17","first-page":"231","volume-title":"Modern Epidemiology","author":"S Greenland","year":"1998","unstructured":"Greenland S, Rothman, KJ. Introduction to categorical statistics. In: Rothman KJ, Greenland S (Eds.), Modern Epidemiology. Philadelphia, PA: Lippincott-Raven, 1998;231\u201352."},{"key":"BF03405330_CR18","first-page":"201","volume-title":"Modern Epidemiology","author":"S Greenland","year":"1998","unstructured":"Greenland S, Rothman, KJ. Fundamentals of epidemiologic data analysis. In: Rothman KJ, Greenland S (Eds.), Modern Epidemiology. Philadelphia: Lippincott William & Wilkins, 1998;201\u201329."},{"issue":"14","key":"BF03405330_CR19","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1001\/jama.280.14.1270","volume":"280","author":"JP Burke","year":"1998","unstructured":"Burke, JP. Antibiotic resistance\u2014squeezing the balloon? JAMA 1998;280(14):1270\u201371.","journal-title":"JAMA"},{"issue":"14","key":"BF03405330_CR20","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1001\/jama.280.14.1233","volume":"280","author":"JJ Rahal","year":"1998","unstructured":"Rahal JJ, Urban C, Horn D, Freeman K, Segal-Maurer J, Maurer J, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 1998;280(14):1233\u201337.","journal-title":"JAMA"},{"issue":"1","key":"BF03405330_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1258\/135581906775094253","volume":"11","author":"DA Marshall","year":"2006","unstructured":"Marshall DA, Gough J, Grootendorst P, Buitendyk M, Jaszewski B, Simonyi S, et al. Impact of administrative restrictions on antibiotic use and expenditures in Ontario: Time series analysis. J Health Services Policy and Research 2006;11(1):13\u201320.","journal-title":"J Health Services Policy and Research"},{"issue":"5","key":"BF03405330_CR22","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1056\/NEJM199201303260503","volume":"326","author":"H Seppala","year":"1992","unstructured":"Seppala H, Nissinen A, Jarvinen H, Huovinen S, Henriksson T, Herva E, et al. Resistance to erythromycin in group A streptococci. N Engl J Med 1992;326(5):292\u201397.","journal-title":"N Engl J Med"},{"key":"BF03405330_CR23","first-page":"35","volume-title":"J Chemother","author":"F Baquero","year":"1999","unstructured":"Baquero F. Evolving resistance patterns of Streptococcus pneumoniae: A link with longacting macrolide consumption? J Chemother 1999;11(Suppl 1):35\u201343."},{"issue":"4","key":"BF03405330_CR24","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1086\/322735","volume":"33","author":"M Pihlajamaki","year":"2001","unstructured":"Pihlajamaki M, Kotilainen P, Kaurila T, Klaukka T, Palva E, Huovinen P. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents. Clin Infect Dis 2001;33(4):483\u201388.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"BF03405330_CR25","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1542\/peds.110.4.805","volume":"110","author":"SI Pelton","year":"2002","unstructured":"Pelton SI, Klein, JO. The future of pneumococcal conjugate vaccines for prevention of pneumococcal diseases in infants and children. Pediatrics 2002;110(4):805\u201314.","journal-title":"Pediatrics"},{"issue":"12","key":"BF03405330_CR26","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1128\/AAC.40.12.2760","volume":"40","author":"C Janior","year":"1996","unstructured":"Janior C, Zeller V, Kitzis MD, Moreau NJ, Gutmann L. High-level fluoroquinolone resistance in Steptococcus pneumoniae requires mutations in parC and gyrA. Antimicrob Agents Chemother 1996;40(12):2760\u201364.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"BF03405330_CR27","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1086\/313954","volume":"31","author":"JG Bartlett","year":"2000","unstructured":"Bartlett JG, Dowell SF, Mandell LA, File Jr TM, Musher DM, Fine, MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 2000;31(2):347\u201382.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"BF03405330_CR28","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1155\/2000\/412616","volume":"7","author":"LA Mandell","year":"2000","unstructured":"Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland, RH. Summary of Canadian guidelines for the initial management of communityacquired pneumonia: An evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society. Can Respir J 2000;7(5):371\u201382.","journal-title":"Can Respir J"}],"container-title":["Canadian Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03405330.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03405330\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03405330.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T12:48:12Z","timestamp":1568378892000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03405330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["BF03405330"],"URL":"https:\/\/doi.org\/10.1007\/bf03405330","relation":{},"ISSN":["0008-4263","1920-7476"],"issn-type":[{"value":"0008-4263","type":"print"},{"value":"1920-7476","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}